Benzo(a)pyrene binding to DNA in organ cultures of human endometrium.

Benzo(a)pyrene was found to bind to DNA in human endometrial tissue in vitro. Among specimens from 41 individuals examined, there was a 70-fold range in the observed specific activities of carcinogen binding to DNA. To determine whether this interindividual variability was correlated with the hormonally determined state of differentiation of the endometrial tissue, this population was subdivided to separate postmenopausal patients from premenopausal patients; among premenopausal patients, further division was made according to location within the menstrual cycle. Tissue obtained late in the proliferative phase or early in the secretory phase of the menstrual cycle had the highest mean specific activity of benzo(a)pyrene binding. In spite of the relatively small group sizes, the observed difference between this and the level of benzo(a)pyrene binding in the mid- and late secretory phases was statistically significant. The average binding level among the small number of patients studied who had entered a natural menopause was lower than the average binding for any of the subgroups of premenopausal patients and significantly lower than the mean for the whole population of premenopausal patients.

[1]  D. Kaufman,et al.  Benzo[a]pyrene metabolism in organ cultures of human endometrium. , 1981, Chemico-biological interactions.

[2]  C. C. Pulliam,et al.  Estrogen and endometrial cancer: cases and two control groups from North Carolina. , 1980, American journal of obstetrics and gynecology.

[3]  S. B. Gusberg.  Current concepts in cancer: The changing nature of endometrial cancer. , 1980, New England Journal of Medicine.

[4]  D. Kaufman,et al.  Studies of human endometrium in organ culture. , 1980, Methods in cell biology.

[5]  C. Harris,et al.  Metabolism of benzo(a)pyrene, N-nitrosodimethylamine, and N-nitrosopyrrolidine and identification of the major carcinogen-DNA adducts formed in cultured human esophagus. , 1979, Cancer research.

[6]  D. English,et al.  Endometrial cancer in relation to patterns of menopausal estrogen use. , 1979, JAMA.

[7]  K. Rothman,et al.  Replacement estrogens and endometrial cancer. , 1979, The New England journal of medicine.

[8]  D. Kaufman,et al.  [3H]Benzo(a)pyrene metabolism in tracheal epithelial microsomes and tracheal organ cultures. , 1978, Cancer research.

[9]  C. Harris,et al.  Metabolism of benzo(a)pyrene and identification of the major benzo(a)pyrene-DNA adducts in cultured human colon. , 1978, Cancer research.

[10]  C. Harris,et al.  Explant culture of human colon. , 1978, Gastroenterology.

[11]  W. Christopherson.  Estrogens and endometrial cancer. , 1977, Journal of the American Medical Association (JAMA).

[12]  C. Harris,et al.  Interindividual variation in binding of benzo[a]pyrene to DNA in cultured human bronchi. , 1976, Science.

[13]  R. Prentice,et al.  ASSOCIATION OF EXOGENOUS ESTROGEN AND ENDOMETRIAL CARCINOMA , 1976 .

[14]  H. Ziel,et al.  Increased risk of endometrial carcinoma among users of conjugated estrogens. , 1975, The New England journal of medicine.

[15]  R. Noyes,et al.  Dating the endometrial biopsy. , 1950, American journal of obstetrics and gynecology.

[16]  J. D. Martin,et al.  Estrogen receptor concentration in normal and pathological human uterine tissues. , 1974, The Journal of clinical endocrinology and metabolism.

[17]  W. Schaffner,et al.  A rapid, sensitive, and specific method for the determination of protein in dilute solution. , 1973, Analytical biochemistry.

[18]  H. Gaylord,et al.  AMERICAN ASSOCIATION FOR CANCER RESEARCH. , 1913, California state journal of medicine.

[19]  For April. , 1903 .